Trip of Compassion: A window into psychedelic-assisted therapies – Wollongong · Mind Medicine Australia
Mind Medicine Australia logo Menu

Trip of Compassion: A window into psychedelic-assisted therapies – Wollongong

Date: Sat 30 October 2021 @ 5:00pm
Location: Gala Twin Cinema 204 Cowper St, Warrawong NSW 2502, Australia

The Wollongong Chapter of Mind Medicine Australia is proud to invite you to:

Trip of Compassion – A window into psychedelic-assisted therapies (incl. panel discussion and Q&A)

Our previous viewings have sold out within days of being announced.

Be sure to grab your tickets early!

Mind Medicine Australia is thrilled to welcome you to our Wollongong Chapter screening of Trip of Compassion, an acclaimed Israeli documentary on MDMA-assisted psychotherapy for the treatment of Post-Traumatic Stress Disorder (PTSD). Trip of Compassion follows a number of patients participating in clinical trials in Israel, and is the first feature documentary to show footage from within psychedelic-assisted therapy sessions.

“I felt like I went through 15 years of psychological therapy in one night.”
–  Patient featured in Trip of Compassion

You can watch the preview here:

Following the screening, there will be a Q & A panel. This will be an opportunity to engage in a discussion about psychedelic-assisted psychotherapies for mental illness broadly, and what Mind Medicine Australia and other local organisations are doing here in Australia.

“Trip of Compassion is the most compelling movie I’ve seen in the last  year!”
– Tim Ferris, acclaimed author and podcaster

Director: Gil Karni,
Producers: Zafrir Kochanovsky & Miri Ezra – ttv Productions
Distributors: GO2FILMS

Date: Saturday 30th of October 2021 – 5:00pm

Location: Gala Cinema, 204 Cowper St. Warrawong NSW 2502

Doors will open at 4:00pm for 5:00pm start – 7:30pm (incl Q&A Panel)

Ticket Price:
$35 General Admission / $25 Concession

——————————————————————

More about medicinal MDMA

Psychedelic-assisted therapies offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

Results from Phase 2 clinical trials over the past decade have been so compelling that the Food and Drug Administration (FDA) in the United States recently designated MDMA-assisted psychotherapy as a ‘Breakthrough Therapy’. This designation highlights the FDA’s anticipation that these therapies may offer substantial advantage over current treatments. If forthcoming Phase 3 results confirm these treatments are effective, MDMA-assisted treatment of PTSD may become a prescription medicine as early as 2021 in some jurisdictions.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

Many thanks to Mind Medicine Australia’s Wollongong Chapter for facilitating this event. Click here for more details or to join the Chapter!

Please support psychedelic research and therapy development by donating to Mind Medicine Australia. The recent pandemic has exacerbated Australia’s mental health epidemic and these treatments have the potential to cure millions of people who are suffering.

We are a small organisation doing big things – we need your support.

Please click here to make a tax-deductible donation.

 

Disclaimer: Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms (for example Facebook, Instagram or Zoom private and public chat forms during a webinar). Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters.

Subscribe to our newsletter

Stay in touch with Mind Medicine Australia:

×